Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vivo

Description of key information
A study combined a 14 -day toxicologcal study in rats with final examination of micronuclei in bone marrow erythrocytes. The resulst at 750 mg/kg were negative and in line with existing literature ( MacGegor, 1990).
Link to relevant study records
Reference
Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Qualifier:
no guideline available
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
Deviations:
not applicable
Principles of method if other than guideline:
A micronucleus assay was done at the end of a 14-day subchronic toxicity study.
GLP compliance:
not specified
Type of assay:
micronucleus assay
Species:
rat
Strain:
Fischer 344
Route of administration:
oral: gavage
Duration of treatment / exposure:
14 days
Frequency of treatment:
once a day
Post exposure period:
24 hours
No. of animals per sex per dose:
5 M and 5 F
Tissues and cell types examined:
Bone marrow cells

No MPCE in males up to 750 mg/kg bw/d, slightly positive in females at 750 mg/kg bw/day, not considered positive due to a low MPCE in the corresponding control female, compared to the other groups tested, including controls of positive controls 6 -MP and cyclophosphamide.

Conclusions:
Interpretation of results (migrated information): negative
In a 1'-day toxicological study in rats, ASA did not induced micronucleus up to 750 mg/kg/day.
Executive summary:

A study combined a 14 -day toxicological study in rats with final examination of micronuclei in bone marrow erythrocytes. The resulst were negative and in line with existing literature ( MacGegor, 1990).

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Additional information

Additional information from genetic toxicity in vivo:

Furthermore all the other in vitro studies were negative.


Justification for selection of genetic toxicity endpoint
Micronucleus study in vivo is the recommended one for C&L.

Justification for classification or non-classification

As in vitro and in vivo studies are concluded negative , ASA is not classified for genotoxicty.